Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary

Simon D S Fraser1, Paul J Roderick, Natasha J McIntyre

  • 1Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, South Academic Block, Southampton General Hospital, Tremona Road, Southampton, Hampshire SO16 6YD, UK. s.fraser@soton.ac.uk

BMC Family Practice
|June 27, 2013
PubMed

Insights

Poor blood pressure (BP) control is common in chronic kidney disease (CKD) patients, especially those with diabetes or albuminuria. Improving BP management in CKD may require combination therapy and addressing adherence.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Poorly controlled hypertension is a significant risk factor for mortality and disease progression in chronic kidney disease (CKD).
  • CKD stage 3 management, including blood pressure (BP) control, primarily occurs in primary care settings in the UK.
  • Effective BP management is crucial for improving patient outcomes in CKD.

Purpose of the Study:

  • To investigate the associations of BP control in individuals diagnosed with CKD stage 3.
  • To assess BP control rates against established guidelines in a primary care setting.

Main Methods:

  • 1,741 patients with CKD stage 3 were recruited from 32 general practices.
  • BP control was evaluated using NICE, KDOQI, and KDIGO guidelines.
  • Logistic regression analysis identified factors associated with BP control.

Main Results:

  • Hypertension prevalence was 88%; achievement rates for NICE, KDOQI, and KDIGO BP targets were 58.1%, 35.9%, and 60.2%, respectively.
  • Patients with diabetes and/or albuminuria had lower BP control rates.
  • Older age, diabetes, and albuminuria were negatively associated with achieving BP targets.

Conclusions:

  • Suboptimal BP control is prevalent in hypertensive CKD patients, particularly those with diabetes and albuminuria.
  • There is a need to improve BP control strategies in CKD management.
  • Combination antihypertensive therapy, alongside adherence and side effect considerations, may enhance BP control.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...